Literature DB >> 16324889

Analysis strategies for a community trial to reduce adolescent ATOD use: a comparison of random coefficient and ANOVA/ANCOVA models.

David M Murray1, M Lee Van Horn, J David Hawkins, Michael W Arthur.   

Abstract

The Community Youth Development Study (CYDS) will evaluate the Communities That Care (CTC) operating system for its effects on alcohol, tobacco, drug use, and other outcomes among adolescents resident in the 24 participating communities. The CYDS employs a combination of both cross-sectional and cohort designs. We use data from an earlier study that included the CYDS communities to estimate power for CYDS intervention effects given several analytic models that might be applied to the multiple baseline and follow-up surveys that define the CYDS cross-sectional design. We compare pre-post mixed-model ANCOVA models against random coefficients models, both in one- and two-stage versions. The two-stage pre-post mixed-model ANCOVA offers the best power for the primary outcomes and will provide adequate power for detection of modest but important intervention effects.

Entities:  

Mesh:

Year:  2006        PMID: 16324889     DOI: 10.1016/j.cct.2005.09.008

Source DB:  PubMed          Journal:  Contemp Clin Trials        ISSN: 1551-7144            Impact factor:   2.226


  16 in total

1.  Comparison of intraclass correlation coefficient estimates and standard errors between using cross-sectional and repeated measurement data: the Safety Check cluster randomized trial.

Authors:  Edward H Ip; Richard Wasserman; Shari Barkin
Journal:  Contemp Clin Trials       Date:  2010-11-08       Impact factor: 2.226

2.  The importance and role of intracluster correlations in planning cluster trials.

Authors:  John S Preisser; Beth A Reboussin; Eun-Young Song; Mark Wolfson
Journal:  Epidemiology       Date:  2007-09       Impact factor: 4.822

3.  Testing communities that care: the rationale, design and behavioral baseline equivalence of the community youth development study.

Authors:  J David Hawkins; Richard F Catalano; Michael W Arthur; Elizabeth Egan; Eric C Brown; Robert D Abbott; David M Murray
Journal:  Prev Sci       Date:  2008-05-31

4.  Effects of the Communities That Care system on cross-sectional profiles of adolescent substance use and delinquency.

Authors:  M Lee Van Horn; Abigail A Fagan; J David Hawkins; Sabrina Oesterle
Journal:  Am J Prev Med       Date:  2014-06-27       Impact factor: 5.043

5.  Person mobility in the design and analysis of cluster-randomized cohort prevention trials.

Authors:  Sam Vuchinich; Brian R Flay; Lawrence Aber; Leonard Bickman
Journal:  Prev Sci       Date:  2012-06

6.  Evaluation of Community-Level Effects of Communities That Care on Adolescent Drug Use and Delinquency Using a Repeated Cross-Sectional Design.

Authors:  Isaac C Rhew; J David Hawkins; David M Murray; Abigail A Fagan; Sabrina Oesterle; Robert D Abbott; Richard F Catalano
Journal:  Prev Sci       Date:  2016-02

7.  Implementation of the Communities That Care Prevention System by Coalitions in the Community Youth Development Study.

Authors:  Michael W Arthur; J David Hawkins; Eric C Brown; John S Briney; Sabrina Oesterle; Robert D Abbott
Journal:  J Community Psychol       Date:  2010-03

8.  The impact on tobacco use of branded youth anti-tobacco activities and family communications about tobacco.

Authors:  Judith Gordon; Anthony Biglan; Keith Smolkowski
Journal:  Prev Sci       Date:  2008-05-14

9.  Sustainability of the Communities That Care prevention system by coalitions participating in the Community Youth Development Study.

Authors:  Kari M Gloppen; Michael W Arthur; J David Hawkins; Valerie B Shapiro
Journal:  J Adolesc Health       Date:  2012-03-03       Impact factor: 5.012

10.  Design and analysis of the Community Youth Development Study longitudinal cohort sample.

Authors:  Eric C Brown; John W Graham; J David Hawkins; Michael W Arthur; Megan M Baldwin; Sabrina Oesterle; John S Briney; Richard F Catalano; Robert D Abbott
Journal:  Eval Rev       Date:  2009-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.